Hutch News

Hutch News

Stories tagged 'Pediatric Oncology'

‘Remarkable’ distinctions in pediatric leukemia point toward improved treatment

Big new study in pediatric and young adult acute myeloid leukemia warns against ‘trickle-down therapeutics’

Dec. 11, 2017 | By Susan Keown / Fred Hutch News Service

Researchers found key differences between the molecular signatures of AML in patients of different ages: So why should we keep assuming that therapies developed for the elderly will work for the young?

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Sept. 14, 2017

An immunotherapy technology developed by Dr. Brian Till with Dr. Oliver Press at Fred Hutchinson Cancer Research Center has been licensed by Mustang Bio Inc., a subsidiary of the biopharmaceutical company Fortress Biotech Inc. The exclusive, worldwide license, announced Sept. 14 by Mustang Bio, will allow a new type of CAR (chimeric antigen receptor) T-cell therapy to be tested in a clinical trial as a treatment for B-cell non-Hodgkin lymphomas. The novel immunotherapy targets CD20, a protein marker on cancer cells in lymphoma.

View story >


At Obliteride, finding strength amid the fear of cancer

Childhood cancer survivor turned oncology nurse rides to raise money for research

Aug. 7, 2017 | By Susan Keown / Fred Hutch News Service

Childhood cancer survivor Katie Bunker, now a pediatric oncology nurse at Seattle Children's Hospital, will be participating this weekend in her second Obliteride, riding 50 miles as a member of Team Baldy Tops.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

June 8, 2017

Fred Hutch epidemiologist Dr. Margaret Madeleine just received a five-year, $2.5 million grant from the National Cancer Institute to test whether the preventive HPV vaccine could be also be used as a therapy anogenital precancers.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

April 6, 2017

Dr. Marie Bleakley receives innovator award for new leukemia immunotherapies; Dr. Anthony Rongvaux receives grant from Lupus Research Alliance; Drs. Benjamin Greer, Wui-Jin Koh win NCCN award.

View story >


The quest to better understand the deadliest childhood leukemia

Oncologists are beginning to leverage unique genomic characteristics of pediatric AML to improve treatment and prognosis

Dec. 7, 2016 | By Sabrina Richards / Fred Hutch News Service

Acute myeloid leukemia is the deadliest leukemia among children. Only 60 percent of patients will achieve long-term remission. But scientists see change on the horizon.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.